Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Convertible Debt (2018 - 2025)

Historic Convertible Debt for LifeMD (LFMDP) over the last 5 years, with Q2 2025 value amounting to $3.5 million.

  • LifeMD's Convertible Debt fell 7018.03% to $3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.5 million, marking a year-over-year decrease of 7018.03%. This contributed to the annual value of $9.9 million for FY2024, which is 4486.16% down from last year.
  • Latest data reveals that LifeMD reported Convertible Debt of $3.5 million as of Q2 2025, which was down 7018.03% from $6.8 million recorded in Q1 2025.
  • In the past 5 years, LifeMD's Convertible Debt registered a high of $18.8 million during Q3 2023, and its lowest value of $3.5 million during Q2 2025.
  • In the last 3 years, LifeMD's Convertible Debt had a median value of $13.2 million in 2023 and averaged $12.3 million.
  • Its Convertible Debt has fluctuated over the past 5 years, first surged by 481.79% in 2024, then crashed by 7018.03% in 2025.
  • Quarter analysis of 3 years shows LifeMD's Convertible Debt stood at $17.9 million in 2023, then tumbled by 44.86% to $9.9 million in 2024, then tumbled by 64.42% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q2 2025, $6.8 million for Q1 2025, and $9.9 million during Q4 2024.